Answers are grounded in this paper and cite their sources.
Aims and Backgrounds Healthcare is a major global carbon emitter, driven by surgical waste, pharmaceutical inefficiencies, and long patient travel. Facial paralysis management requires complex, multidisciplinary care where delays degrade outcomes. This review synthesizes literature on sustainability and accessibility across the facial paralysis care continuum to formulate evidence-based clinical recommendations. Patient Selection Following PRISMA-ScR guidelines, PubMed, Embase, Cochrane CENTRAL, and Scopus were searched through June 2026 using PICOS criteria to evaluate telemedicine, multidisciplinary care, ambulatory surgery, low-resource surgical alternatives, and vial protocols. Techniques Virtual visits reduced follow-up times by ~50% and costs up to 79.8% while maintaining high satisfaction. Multidisciplinary clinic models consolidated care, reducing provider visits (4.8 vs. 6.8; P < .01) and charges by 50%. Ambulatory surgical centers (ASCs) lowered costs by 26% and reduced readmissions relative to inpatient settings. Temporalis tendon transfer (TTT) and selective neurolysis offer single-stage, low-resource outpatient alternatives to complex microvascular procedures. Multi-patient botulinum toxin vial-sharing protocols successfully mitigated pharmaceutical waste with negligible complication rates. Conclusions and Clinical Relevance Transitioning toward digital health, multidisciplinary pathways, ambulatory routing, and optimized pharmaceutical protocols enhances sustainability and geographic access while preserving high-quality clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Makabeh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: